肺癌A549细胞源性外泌体中lncRNA DUXAP8对肺癌细胞生长和肿瘤免疫逃逸的作用及其机制

doi:10.13481/j.1671-587X.20250412

Abstract

Abstract:

Objective To discuss the effect of long non-coding RNA （lncRNA） DUXAP8 in exosomes （Exo） derived from the lung cancer A549 cells on the growth and immune escape of the lung cancer cells， and to clarify the mechanism. Methods The human lung cancer cell line A549 was cultured， and its exosomes were extracted and identified. The A549 cells were treated with PKH67-labeled Exo to observe the uptake of Exo by A549 cells. Real-time fluorescence quantitative PCR （RT-qPCR） method was used to detect the expression level of lncRNA DUXAP8 in A549 cells before and after Exo treatment. The A549 cells were divided into control group （no treatment）， Exo group （A549 cells treated with Exo）， Exo+sh-NC group （A549 cells treated with Exo and then transfected with sh-NC）， and Exo+ sh-DUXAP8 group （A549 cells treated with Exo and then transfected with sh-DUXAP8）. RT-qPCR method was used to detect the expression level of lncRNA DUXAP8 in A549 cells in various groups； colony formation assay was used to detect the colony formation abilities of the A549 cells in various groups； 5-ethynyl-2'-deoxyuridine （EdU） staining method was used to detect the proliferation abilities of the A549 cells in various groups. After co-culturing A549 cells in various groups with human peripheral blood lymphocytes， flow cytometry was used to detect the percentages of activated CD8+ T lymphocytes in the human peripheral blood lymphocytes in various groups； 3-（4，5-dimethylthiazol-2-yl）-2， 5-diphenyltetrazolium bromide （MTT） method was used to detect the killing rates of human peripheral blood lymphocytes on the A549 cells in various groups. Results The diameter of Exo vesicles was 50-150 nm， and the exosome-specific marker proteins cluster of differentiation 63（CD63）， cluster of differentiation 9（CD9）， tumor susceptibility gene 101（TSG101）， and heat shock protein 70（HSP70） were positively expressed， indicating successful exosome extraction. A549 cells efficiently took up PKH67-labeled Exo. The RT-PCR results showed that compared with A549 cells cultured alone， the expression level of lncRNA DUXAP8 in the A549 cells was increased after treatment with Exo derived from A549 cells （P<0.05）. compared with control group， the expression level of lncRNA DUXAP8 in the A549 cells in Exo group was increased （P<0.05）； compared with Exo group， the expression level of lncRNA DUXAP8 in the A549 cells in Exo+sh-DUXAP8 group was decreased （P<0.05）， while there were no significant difference in the expression level of IncRNA DUXAP8 in the cells in Exo+sh-NC group （P>0.05）. The colony formation assay results showed that compared with control group， the number of colony formation of the A549 cells in Exo group was increased （P<0.05）； compared with Exo group， the number of colony formation of the A549 cells in Exo+sh-DUXAP8 group was decreased （P<0.05）， while there was no significant difference in the number of colony formation of the A549 cells in Exo+sh-NC group （P>0.05）. The EdU staining results showed that compared with control group， the EdU-positive rate of the A549 cells in Exo group was increased （P<0.05）； compared with Exo group， the EdU-positive rate in A549 cells in Exo+sh-DUXAP8 group was decreased （P<0.05）， while there was no significant difference in the EDU-positive rate in the cells in Exo+sh-NC group （P>0.05）. The flow cytometry results showed that compared with control group， the percentage of activated CD8+T lymphocytes in the human peripheral blood lymphocytes in Exo group was decreased （P<0.05）； compared with Exo group， the percentage of activated CD8+T lymphocytes in the human peripheral blood lymphocytes in Exo+ sh-DUXAP8 group was increased （P<0.05）， while there was no significant difference in the percentage of activated CD8+T lymphaytes in Exo+sh-NC group （P>0.05）. The MTT assay results showed that compared with control group， the killing rate of human peripheral blood lymphocytes on the A549 cells in Exo group was decreased （P<0.05）； compared with Exo group， the killing rate of human peripheral blood lymphocytes on A549 cells in Exo+sh-DUXAP8 group was increased （P<0.05）， while no significant difference was observed in Exo+sh-NC group （P>0.05）. Conclusion The lncRNA DUXAP8 in exosomes derived from the lung cancer A549 cells promotes the proliferation of lung cancer cells and tumor immune escape.

Key words: Lung neoplasms, Exosomes, Long non-coding RNA, DUXAP8, Cell proliferation, Immune escape

CLC Number:

R734.2

Xiaoshuang HE,Lina XU,Mei CUI,Yu ZHAO,Bei WANG,Zheng HUANG,Yuchao WANG,Wenyan XIN,Chao WU. Effects of lncRNA DUXAP8 in lung cancer A549 cells-derived exosomes on lung cancer cell growth and its mechnism[J].Journal of Jilin University(Medicine Edition), 2025, 51(4): 958-967.

Figures/Tables 11

Fig. 1

Fig. 2

Tab.1

Tab.2

Fig. 3

Fig. 4

Fig. 5

Fig. 6

Fig. 7

Fig. 8

Tab.3

References 19

[1]	YAO J， NOVOSEL M， BELLAMPALLI S， et al. Lung cancer supportive care and symptom management［J］. Hematol Oncol Clin North Am， 2023， 37（3）： 609-622.
[2]	JHA S K， DE RUBIS G， DEVKOTA S R， et al. Cellular senescence in lung cancer： molecular mechanisms and therapeutic interventions［J］. Ageing Res Rev， 2024， 97： 102315.
[3]	SATHISH G， MONAVARSHINI L K， SUNDARAM K， et al. Immunotherapy for lung cancer［J］. Pathol Res Pract， 2024， 254： 155104.
[4]	KALLINGAL A， OLSZEWSKI M， MACIEJEWSKA N， et al. Cancer immune escape： the role of antigen presentation machinery［J］. J Cancer Res Clin Oncol， 2023， 149（10）： 8131-8141.
[5]	ROCHA K C E， YING W， OLEFSKY J M. Exosome-mediated impact on systemic metabolism［J］. Annu Rev Physiol， 2024， 86： 225-253.
[6]	KWANTWI L B. Exosome-mediated crosstalk between tumor cells and innate immune cells： implications for cancer progression and therapeutic strategies［J］. J Cancer Res Clin Oncol， 2023， 149（11）： 9487-9503.
[7]	REGGIARDO R E， MAROLI S V， KIM D H. LncRNA biomarkers of inflammation and cancer［J］. Adv Exp Med Biol， 2022， 1363： 121-145.
[8]	YAO Z T， YANG Y M， SUN M M， et al. New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer［J］. Cancer Commun （Lond）， 2022， 42（2）： 117-140.
[9]	WU C， SONG W， WANG Z N， et al. Functions of lncRNA DUXAP8 in non-small cell lung cancer［J］. Mol Biol Rep， 2022， 49（3）： 2531-2542.
[10]	姜怡，蔡雨晴，张朋，等. 益气养阴解毒方及黄芪甲苷体外对CTLA-4介导的肺癌免疫逃逸的影响［J］. 中成药， 2021， 43（8）： 2173-2177.
[11]	MASHOURI L， YOUSEFI H， AREF A R， et al. Exosomes： composition， biogenesis， and mechanisms in cancer metastasis and drug resistance［J］. Mol Cancer， 2019， 18（1）： 75.
[12]	ZHANG L， YU D H. Exosomes in cancer development， metastasis， and immunity［J］. Biochim Biophys Acta Rev Cancer， 2019， 1871（2）： 455-468.
[13]	SHI Z H， LI Z M， JIN B， et al. Loss of LncRNA DUXAP8 synergistically enhanced sorafenib induced ferroptosis in hepatocellular carcinoma via SLC7A11 de-palmitoylation［J］. Clin Transl Med， 2023， 13（6）： e1300.
[14]	LEI C J， LI S T， FAN Y， et al. LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway［J］. Cancer Biol Ther， 2022， 23（1）： 1-13.
[15]	PANG R Z， YANG S. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR-20b-5p/SOS1 axis［J］. Oncol Rep， 2021， 45（5）： 64.
[16]	LIU Y， ZHANG G M， CHEN H， et al. Silencing lncRNA DUXAP8 inhibits lung adenocarcinoma progression by targeting miR-26b-5p［J］. Biosci Rep， 2021， 41（1）： BSR20200884.
[17]	ROSTAMI S， NABI M， NAGHAVI P， et al. Overexpression of the long non-coding RNA NeSt and FOXCUT in early stages of prostate cancer samples as promising biomarkers［J］. Clin Lab， 2019， 65（11）：2063-2069.
[18]	XIONG T F， HUANG C C， LI J F， et al. LncRNA NRON promotes the proliferation， metastasis and EMT process in bladder cancer［J］. J Cancer， 2020， 11（7）： 1751-1760.
[19]	ZHANG M， WANG R J， ZHAO X， et al. LncRNA LINK-a regulates ROCK1 expression in early-stage pancreatic adenocarcinoma［J］. Exp Ther Med， 2020， 19（3）： 1933-1939.

Group	Expression level of lncRNA DUXAP8
A549	1.00±0.14
Exo+A549	3.12±0.26
t	17.59
P	<0.001

Group	Expression level of lncRNA DUXAP8
Control	1.00±0.13
Exo	3.37±0.26^*
Exo+sh-NC	3.42±0.21^*
Exo+sh-DUXAP8	1.17±0.11^△
F	304.30
P	<0.001

Group	Killing rate
Control	13.34±2.23
Exo	6.28±1.41^*
Exo+sh-NC	6.44±1.05^*
Exo+sh-DUXAP8	15.46±2.73^△
F	34.49
P	<0.001

Effects of lncRNA DUXAP8 in lung cancer A549 cells-derived exosomes on lung cancer cell growth and its mechnism

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 11

References 19

Related Articles 15

Metrics

Comments

Recommended 10

[1]	Lina XU,Xiaoshuang HE,Wenyan XIN,Chao WU. Improvement effect of bone marrow mesenchymal stem cell-derived exosomes on airway resistance and lung tissue lesion in mice of asthmatic models and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 602-611.
[2]	Xiao ZHOU,Haitao DAI,Yunshan DING,Linjie ZHANG,Nan WU. Network pharmacology analysis and in vitro experimental validation of anticancer effect of grape seed proanthocyanidins against oral squamous cell carcinoma [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 651-662.
[3]	Qiaotong REN,Weihua WU,Xingxiang WANG,Shichao WANG,Yipeng CHENG,Chun LI. Effect of interleukin-17 recepter B gene silencing on proliferation, invasion and apoptosis of lung adenocarcinoma A549 cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 738-745.
[4]	Di LI,Yang SU,Yong ZHANG,Jiaoqi WANG,Xiaofei ZHANG,Xuebing ZHAO. Expression levels of miR-328-3p and miR-671-5p in serum exosomes of Kawasaki disease model mice and their significance [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 359-365.
[5]	Yao ZHENG,Mingxia FU,Weichen WANG,Weiwei CHEN,Yuchen HAN,Yu BAI,Jiajia AN. Effect of sodium selenite on biological behaviors of breast cancer doxorubicin-resistant MCF-7/ADR cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 410-417.
[6]	Yu ZHAO,Xiaoshuang HE,Xiaoyin DONG,Fengyi GAO,Jiageng HE. Regulatory effect of lncRNA urothelial carcinoembryonic antigen 1 on anoikis in human gastrointestinal stromal tumor cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 429-439.
[7]	Li ZHAI,Meng CHEN,Jianbo LUO,Aili ZHANG,Liangxiao WANG,Ying WEI,Xi ZHANG. Targeting relationship between miR-214-3p and EZH2 and its effects on proliferation， invasion， and apoptosis of ovarian cancer SKOV3 cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 460-468.
[8]	Hong LI,Panpan YU,Zouyu ZHAO,Chongfeng SUN,Hui QIAO,Ping YANG. Expression of GSTO1 in ovarian cancer tissue and effect of N-glycosylation site mutations on biological behaviors of epithelial ovarian cancer cells [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 469-482.
[9]	Huiying YANG,Weihong LIANG,Xinru XU,Haodan SUN,Xin JIAO,Haiping WANG. Research progress in effect of bone marrow mesenchymal stem cells on differentiation induction of cardiomyocyte-like cells, protection of cardiomyocytes, and myocardial-related diseases [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 281-289.
[10]	Yan ZHAO,Huawei WU. Inhibitory effect of inhibition of miR-17-5p on proliferation of spinal cord astrocytes of rats induced by scratch injury through targeting Mfn2 expression [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 81-92.
[11]	Xiaohan YAO,Mingchen YAO,Zhiqing WANG,Heyang LI,Yan YAN,Ningjing LEI. Effect of silencing GPR139 gene on proliferation, apoptosis and autophagy of breast cancer cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 1-9.
[12]	Sifan FENG,Yunfeng LI,Jiaying WANG,Fubin MA,Yan WANG. Effects of heme-binding protein 1 gene knockdown on proliferation, migration, and inflammatory response of microglia BV2 and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1532-1541.
[13]	Jing LIU,Yan WANG,Xu HUANG. Promoting effect of overexpressed circRNAs-modified dental pulp stem cell-derived exosomes on angiogenesis of human umbilical vein endothelial cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1561-1570.
[14]	Lulu FU,Yinggang ZOU,Xiaoyu ZHENG,Xueying ZHANG,Jingshun ZHANG,Min WANG,Qiang ZHANG,Lianwen ZHENG. Expression of placenta expressed transcription factor 1 in ovarian tissue of polycystic ovary syndrome rats and its effect on proliferation of rat ovarian granulosa cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1177-1184.
[15]	Wenxuan LI,Minru ZONG. Research progress in role of migration of Schwann cells in repairment of peripheral nerve injury [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1137-1144.